Regis Technologies
Christopher Kassl, PhD, is a seasoned professional in the field of synthetic organic chemistry and process chemistry, currently serving as Group Leader for the Process Chemistry Division and previously as Principal and Senior Research Scientist at Regis Technologies since April 2019. With expertise in project management and research chemistry, Christopher contributes to the development of client-driven chemical R&D and GMP production at a leading API manufacturer. Prior experience includes working as a Synthetic Organic Chemist at Dow AgroSciences from March 2016 to March 2019 and serving as a Chemistry Research Assistant and Ph.D. Candidate at the University of Iowa from August 2009 to December 2015. Christopher holds a Doctor of Philosophy in Organic Chemistry from the University of Iowa and a Bachelor of Science in Chemistry from Augustana College.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.